TDF (tenofovir disoproxil fumarate) Lawsuits

Baron & Budd has represented individuals in lawsuits against major pharmaceutical companies for more than 40 years. If you took one of these drugs and suffered harm as a result, we may be able to help.

How TDF is Supposed to Work

Unfortunately, there is no cure for HIV (human immunodeficiency virus), which attacks the immune system of the body. If not held in check, HIV can rapidly multiply throughout the body, destroying immune cells and leaving the body susceptible to a host of severe infections. Medications can help patients control the virus so that they can continue to live a normal life and lower the risk of infection to others.

The U.S. Food and Drug Administration (FDA) approved TDF for use in adults in 2001. TDF medications are designed to block the formation of an enzyme that allows the virus to multiply. In doing so, it helps to reduce the amount of HIV in the body and can help people with HIV live longer. More recently, TDF medications were approved for adults and adolescents at risk of HIV, as TDF can lower the chance of patients contracting HIV.

Severe Problems

However, TDF has been linked to several severe kidney and bone injuries. Researchers conducting a 2017 study found that TDF use can lead to chronic kidney disease. According to the study, the longer someone uses the drug, the higher the risk of developing the condition. TDF use may also increase a patient’s risk for bone loss. In 2016, researchers indicated that there was greater bone mineral density loss associated with TDF than with tenofovir alafenamide fumarate (“TAF”). A 2018 study found that people who took medications containing the substance had substantially less hip bone density.